Cargando…
Oral administration of EP4-selective agonist KAG-308 suppresses mouse knee osteoarthritis development through reduction of chondrocyte hypertrophy and TNF secretion
Osteoarthritis (OA) is one of the world’s most common degenerative diseases, but there is no disease-modifying treatment available. Previous studies have shown that prostaglandin E2 (PGE(2)) and PGE2 receptor 4 (EP(4)) are involved in OA pathogenesis; however, their roles are not fully understood. H...
Autores principales: | Murahashi, Yasutaka, Yano, Fumiko, Chijimatsu, Ryota, Nakamoto, Hideki, Maenohara, Yuji, Amakawa, Masahiro, Miyake, Yoshihide, Yamanaka, Hiroyuki, Iba, Kousuke, Yamashita, Toshihiko, Tanaka, Sakae, Saito, Taku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937271/ https://www.ncbi.nlm.nih.gov/pubmed/31889132 http://dx.doi.org/10.1038/s41598-019-56861-6 |
Ejemplares similares
-
Intra-articular administration of IκBα kinase inhibitor suppresses mouse knee osteoarthritis via downregulation of the NF-κB/HIF-2α axis
por: Murahashi, Yasutaka, et al.
Publicado: (2018) -
Runx1 contributes to articular cartilage maintenance by enhancement of cartilage matrix production and suppression of hypertrophic differentiation
por: Yano, Fumiko, et al.
Publicado: (2019) -
Electronic Properties of Fluoride and Half–fluoride Superlattices KZnF(3)/KAgF(3) and SrTiO(3)/KAgF(3)
por: Yang, Xiaoping, et al.
Publicado: (2015) -
Enhancement of chondrogenic differentiation supplemented by a novel small compound for chondrocyte-based tissue engineering
por: Hamamoto, Shuichi, et al.
Publicado: (2020) -
Runx2 and Runx3 differentially regulate articular chondrocytes during surgically induced osteoarthritis development
por: Nagata, Kosei, et al.
Publicado: (2022)